0000000000417632

AUTHOR

Gondos Adam

showing 3 related works from this author

Survival of stomach and esophagus cancer patients in Germany in the early 21st century

2012

Esophagus and stomach cancers are associated with poor prognosis. But most published population-based cancer survival estimates for stomach and esophagus cancer refer to survival experience of patients diagnosed in the 1990s or earlier years. The aim of this study was to provide up-to-date survival estimates and trends for patients with stomach and esophagus cancer in Germany.Our analysis is based on data from 11 population-based cancer registries, covering 33 million inhabitants. Patients diagnosed with stomach and esophagus cancer in 1997-2006 were included. Period analysis was used to derive five-year relative survival estimates and trends by age, sex, cancer subsite, and stage for the t…

AdultMalemedicine.medical_specialtyEsophageal NeoplasmsPopulationAdenocarcinomaGastroenterologyStomach NeoplasmsGermanyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRegistriesSex DistributionEsophagusStage (cooking)educationSurvival analysisAgededucation.field_of_studyRelative survivalbusiness.industryStomachCancerHematologyGeneral MedicineMiddle Agedmedicine.diseaseSurvival AnalysisUnited StatesSurvival Ratemedicine.anatomical_structureOncologyPeriod AnalysisFemaleEsophagogastric JunctionbusinessSEER ProgramActa Oncologica
researchProduct

Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century.

2012

This study provides up-to-date and detailed cancer survival estimates of German patients with non-Hodgkin lymphoma (NHL, International Statistical Classification of Diseases 10th Revision [ICD-10] codes C82-C85) based on data from 11 cancer registries. Period analysis was used to calculate 5-year relative survival in 2002-2006, overall and by gender, age and histology. Comparison was made with patients with NHL in the United States (US) Surveillance, Epidemiology and End Results database in the same time period. Overall 5-year relative survival for patients with NHL in Germany in 2002-2006 was 62.8% and in the US was 65.1%. Survival decreased with age from 81.7% at age 15-49 to 46.5% at age…

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentFollicular lymphomaHistory 21st CenturyYoung AdultOlder patientshemic and lymphatic diseasesInternal medicineGermanyEpidemiologymedicineHumansRegistriesAgedAged 80 and overRelative survivalbusiness.industryLymphoma Non-HodgkinCancerHematologyHistory 20th CenturyMiddle Agedmedicine.diseaseUnited StatesLymphomaOncologyImmunologyPeriod AnalysisHodgkin lymphomaFemalebusinessSEER ProgramLeukemialymphoma
researchProduct

Survival of cervical cancer patients in Germany in the early 21st century: A period analysis by age, histology, and stage

2012

Background: Population-based studies on endometrial cancer providing survival estimates by age, histology, and stage have been sparse. We aimed to derive most up-to-date and detailed survival estimates for endometrial cancer patients in Germany. Methods: We used a pooled German national dataset including data from 11 cancer registries covering a population of 33 million people. 30,906 patients diagnosed with endometrial cancer in 1997-2006 were included. Period analysis was performed to calculate 5-year relative survival (RS) in 2002-2006. Trends in survival between 2002 and 2006 were examined using model-based period analysis. Age-adjustment was performed using five age groups (15-44, 45-5…

Adultmedicine.medical_specialtyAdolescentPopulationUterine Cervical NeoplasmsAge DistributionGermanyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRegistriesStage (cooking)educationSurvival analysisAgedNeoplasm StagingCervical cancereducation.field_of_studyRelative survivalbusiness.industryEndometrial cancerAge FactorsCancerHematologyGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurvival AnalysisSurgerySurvival RateOncologyFemaleSarcomabusinessActa Oncologica
researchProduct